Value-based purchasing of medical devices.
BACKGROUND
Health care in the United States is known for its continued innovation and production of new devices and techniques. While the intention of these devices is to improve the delivery and outcome of patient care, they do not always achieve this goal. As new technologies enter the market, hospitals and physicians must determine which of these new devices to incorporate into practice, and it is important these devices bring value to patient care. We provide a model of a physician-engaged process to decrease cost and increase review of physician preference items.


OBJECTIVE
We describe the challenges, implementation, and outcomes of cost reduction and product stabilization of a value-based process for purchasing medical devices at a major academic medical center.


METHODS
We implemented a physician-driven committee that standardized and utilized evidence-based, clinically sound, and financially responsible methods for introducing or consolidating new supplies, devices, and technology for patient care. This committee worked with institutional finance and administrative leaders to accomplish its goals.


RESULTS
Utilizing this physician-driven committee, we provided access to new products, standardized some products, decreased costs of physician preference items 11% to 26% across service lines, and achieved savings of greater than $8 million per year.


CONCLUSIONS
The implementation of a facility-based technology assessment committee that critically evaluates new technology can decrease hospital costs on implants and standardize some product lines.
Department of Orthopaedic Surgery and Rehabilitation, Vanderbilt Orthopaedic Institute Center for Health Policy, 1215 21st Avenue, Medical Center East Suite 4200, Nashville, TN 37232-8774, USA. William.obremskey@vanderbilt.edu
William T
WT
Obremskey
Teresa
T
Dail
A Alex
AA
Jahangir
D017046:Cost Savings / Q000191:economics*; D004864:Equipment and Supplies / Q000191:economics*; D017048:Health Care Costs; D006801:Humans; D013673:Technology Assessment, Biomedical / Q000191:economics*; D014481:United States